biological therapy

Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs
John D Isaacs, Gerd R Burmester

Annals of the Rheumatic Diseases Aug 2020, 79 (8) 991-993; DOI: 10.1136/annrheumdis-2020-218019
Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD
Maurizio Benucci, Arianna Damiani, Gianfranco Giannasi, Francesca Li Gobbi, Luca Quartuccio, Valentina Grossi, Maria Infantino, Mariangela Manfredi

Annals of the Rheumatic Diseases Jul 2020, annrheumdis-2020-218214; DOI: 10.1136/annrheumdis-2020-218214
Should patients starting biologics be screened for COVID-19?
Jesus Alberto Cardenas-de la Garza, Rosa I Arvizu-Rivera, Dionicio Angel Galarza-Delgado

Annals of the Rheumatic Diseases Jul 2020, annrheumdis-2020-218437; DOI: 10.1136/annrheumdis-2020-218437
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study
Carlo Salvarani, Gianluigi Bajocchi, Pamela Mancuso, Elena Galli, Francesco Muratore, Luigi Boiardi, Mariagrazia Catanoso, Nicolò Pipitone, Giulia Cassone, Nicolò Girolimetto, Stefania Croci, Luca Cimino, Federeica Gradellini, Marina Beltrami, Vito Di Lernia, Giovammi Dolci, Marco Massari, Anna Maria Marata, Massimo Costantini, Paolo Giorgi Rossi

Annals of the Rheumatic Diseases Jul 2020, 79 (7) 986-988; DOI: 10.1136/annrheumdis-2020-217903
Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic
Hendrik Schulze-Koops, Christof Specker, Christof Iking-Konert, Julia Holle, Frank Moosig, Klaus Krueger

Annals of the Rheumatic Diseases Jun 2020, 79 (6) 840-842; DOI: 10.1136/annrheumdis-2020-217628
Public/private partnerships, at what price?
Maarten Boers

Annals of the Rheumatic Diseases May 2020, annrheumdis-2020-217664; DOI: 10.1136/annrheumdis-2020-217664
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
Sara Monti, Silvia Balduzzi, Paolo Delvino, Elisa Bellis, Verdiana Serena Quadrelli, Carlomaurizio Montecucco

Annals of the Rheumatic Diseases May 2020, 79 (5) 667-668; DOI: 10.1136/annrheumdis-2020-217424
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
Carina Mihai, Rucsandra Dobrota, Maria Schröder, Alexandru Garaiman, Suzana Jordan, Mike Oliver Becker, Britta Maurer, Oliver Distler

Annals of the Rheumatic Diseases May 2020, 79 (5) 668-669; DOI: 10.1136/annrheumdis-2020-217442

Main menu

biological therapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

biological therapy

Pages